Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int J Med Sci, 9, 193, 10.7150/ijms.3635 Brenner, 2018, The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention, Br J Cancer, 119, 785, 10.1038/s41416-018-0264-x Arnold, 2017, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, 683, 10.1136/gutjnl-2015-310912 Swellengrebel, 2011, Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer, Br J Surg, 98, 418, 10.1002/bjs.7315 Brunner, 2016, The rationale of combined radiotherapy and chemotherapy – joint action of Castor and Pollux, Best Pract Res Clin Gastroenterol, 30, 515, 10.1016/j.bpg.2016.07.002 Bartelink, 2002, The combined use of radiotherapy and chemotherapy in the treatment of solid tumours, Eur J Cancer, 38, 216, 10.1016/S0959-8049(01)00363-X Greenhalgh, 2016, Combination of novel agents with radiotherapy to treat rectal cancer statement of search strategies used and sources of information, Clin Oncol, 28, 116, 10.1016/j.clon.2015.11.002 Verhagen, 2015, Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells, Radiother Oncol, 1 Zhivotovsky, 1999, Tumor radiosensitivity and apoptosis, Exp Cell Res, 248, 10, 10.1006/excr.1999.4452 Belka, 2004, Apoptosis-modulating agents in combination with radiotherapy – current status and outlook, Int J Radiat Oncol Biol Phys, 58, 542, 10.1016/j.ijrobp.2003.09.067 Smyth, 2003, Nature’s TRAIL — on a path to cancer, Immunotherapy, 18, 1 Takeda, 2001, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, Nat Med, 7, 94, 10.1038/83416 Ashkenazi, 2002, Targeting death and decoy receptors of the tumour-necrosis factor superfamily, Nat Rev Cancer, 2, 420, 10.1038/nrc821 Falschlehner, 2007, TRAIL signalling: decisions between life and death, Int J Biochem Cell Biol, 10.1016/j.biocel.2007.02.007 Von Karstedt, 2017, Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy, Nat Rev Cancer, 17, 352, 10.1038/nrc.2017.28 Wang, 2003, TRAIL, and apoptosis induction by TNF-family death receptors, Oncogene, 22, 8628, 10.1038/sj.onc.1207232 Emery, 1998, Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL, J Biol Chem, 273, 14363, 10.1074/jbc.273.23.14363 Gieffers C, Kluge M, Merz C, Fricke H, Hill O. APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fc γ receptors APG350 induces superior clustering of TRAIL receptors and cross-linking via Fc g receptors; 2013. AACR New drugs on the horizon_Susan Morgan-Lappe_published abstract. Hengartner MO. Hengartner2000.pdf; 2000. p. 810–6. Amarante-Mendes, 2015, Therapeutic applications of TRAIL receptor agonists in cancer and beyond, Pharmacol Ther, 155, 117, 10.1016/j.pharmthera.2015.09.001 Verbrugge, 2008, Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway, Oncogene, 27, 574, 10.1038/sj.onc.1210696 Niemoeller, 2013, Radiotherapy and TRAIL for cancer therapy, Cancer Lett, 332, 184, 10.1016/j.canlet.2011.07.003 Maduro, 2008, Targeting pro-apoptotic TRAIL receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis, Int J Radiat Oncol Biol Phys, 72, 543, 10.1016/j.ijrobp.2008.06.1902 Werner, 2002, TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from Truncated Bid, J Biol Chem, 277, 40760, 10.1074/jbc.M204351200 Holland, 2013, Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL, Cancer Lett, 332, 156, 10.1016/j.canlet.2010.11.001 Den Hollander, 2013, Translating TRAIL-receptor targeting agents to the clinic, Cancer Lett, 332, 194, 10.1016/j.canlet.2012.04.007 Lemke, 2014, Getting TRAIL back on track for cancer therapy, Cell Death Differ, 21, 1350, 10.1038/cdd.2014.81 Holland, 2013, Death receptor agonist therapies for cancer, which is the right TRAIL?, Cytokine Growth Factor Rev Duval, 2017, Modeling physiological events in 2D vs. 3D cell culture, Physiology, 32, 266, 10.1152/physiol.00036.2016 Weeber, 2017, Tumor organoids as a pre-clinical cancer model for drug discovery, Cell Chem Biol, 24, 1092, 10.1016/j.chembiol.2017.06.012 Sträter, 2002, Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter, Clin Cancer Res, 8, 3734 Weeber, 2015, Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases, Proc Natl Acad Sci USA, 112, 13308, 10.1073/pnas.1516689112 Clevers, 2016, Modeling development and disease with organoids, Cell, 165, 1586, 10.1016/j.cell.2016.05.082 Jung P et al. Isolation and in vitro expansion of. p. 1225–7. Sato, 2011, Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium, Gastroenterology, 141, 1762, 10.1053/j.gastro.2011.07.050 Zerp, 2009, AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis, Radiat Oncol, 4, 47, 10.1186/1748-717X-4-47 Zerp, 2015, Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy : data from in vitro and clinical pharmacokinetic studies in head and neck cancer, Radiat Oncol, 1 Chou, 2010, Drug combinatin studies and their synergy quantifcation using the Chou-Talalay method, Cancer Res, 70, 440, 10.1158/0008-5472.CAN-09-1947 Abhari BA et al. APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fcg receptors; 2013. p. 2735–48. Ratain, 2019, Phase 1, first-in-human study of TRAIL receptor agonist fusion protein ABBV-621, J Clin Oncol, 37, 3013, 10.1200/JCO.2019.37.15_suppl.3013 Dijkstra, 2018, Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids, Cell, 174, 1586, 10.1016/j.cell.2018.07.009 Nagle, 2016, The in vitro response of tissue stem cells to irradiation with different linear energy transfers, Radiat Oncol Biol, 95, 103, 10.1016/j.ijrobp.2016.02.020